Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.

<h4>Background</h4>Safety regarding switching from vitamin K antagonist (VKA) to dabigatran therapy in post-ablation patients has never been investigated and safety data for this is urgently needed. The objective of this study was to examine if switch from VKA to dabigatran increased the risk of str...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jannik Langtved Pallisgaard, Gunnar Hilmar Gislason, Christian Torp-Pedersen, Christina Ji-Young Lee, Caroline Sindet-Pedersen, Laila Staerk, Jonas Bjerring Olesen, Tommi Bo Lindhardt
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2016-01-01
coleção:	PLoS ONE
Acesso em linha:	https://doi.org/10.1371/journal.pone.0161768
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!